Maxcyte (MXCT) Share-based Compensation (2020 - 2026)
Maxcyte (MXCT) reported Share-based Compensation of $1.1 million for Q1 2026, down 62.45% year-over-year from $3.0 million in Q1 2025, and up 61.61% on a QoQ basis from $706000.0 in Q4 2025.
Maxcyte (MXCT) has 7 years of Share-based Compensation data on file, last reported at $1.1 million in Q1 2026.
- Quarterly Share-based Compensation fell 62.45% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.3 million (down 44.19% YoY) and the FY2025 annual result came in at $9.2 million, down 29.58% from the prior year.
- Share-based Compensation improved to $1.1 million in Q1 2026 per MXCT's latest filing, from $706000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $3.6 million in Q3 2023 and bottomed at $706000.0 in Q4 2025.
- The 5-year median for Share-based Compensation is $3.1 million (2024), against an average of $2.9 million.
- The widest annual swing landed in 2022, when Share-based Compensation jumped 86.57%; it then plunged 77.47% in 2025.
- Tracing MXCT's Share-based Compensation over 5 years: stood at $3.1 million in 2022, then climbed by 14.62% to $3.6 million in 2023, then fell by 12.31% to $3.1 million in 2024, then sank by 77.47% to $706000.0 in 2025, then jumped by 61.61% to $1.1 million in 2026.
- Per Business Quant, the three latest MXCT Share-based Compensation figures stand at $1.1 million (Q1 2026), $706000.0 (Q4 2025), and $2.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 87.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 94.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 43.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 12.90 Mn |
| 10 | Maxcyte | 129.85 Mn | 129.85 Mn | 8.08 Mn | 1.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.14 Mn |
| Mar 31, 2026 | 1.14 Mn |
| Dec 31, 2025 | 706,000.00 |
| Dec 31, 2025 | 706,000.00 |
| Sep 30, 2025 | 1.95 Mn |
| Sep 30, 2025 | 1.95 Mn |
| Jun 30, 2025 | 3.51 Mn |
| Jun 30, 2025 | 3.51 Mn |
| Mar 31, 2025 | 3.04 Mn |
| Mar 31, 2025 | 3.04 Mn |
| Dec 31, 2024 | 3.13 Mn |
| Dec 31, 2024 | 3.13 Mn |
| Sep 30, 2024 | 3.37 Mn |
| Sep 30, 2024 | 3.37 Mn |
| Jun 30, 2024 | 3.56 Mn |
| Jun 30, 2024 | 3.56 Mn |
| Mar 31, 2024 | 3.02 Mn |
| Mar 31, 2024 | 3.02 Mn |
| Dec 31, 2023 | 3.57 Mn |
| Dec 31, 2023 | 3.57 Mn |
| Sep 30, 2023 | 3.61 Mn |
| Sep 30, 2023 | 3.61 Mn |
| Jun 30, 2023 | 3.52 Mn |
| Jun 30, 2023 | 3.52 Mn |
| Mar 31, 2023 | 3.28 Mn |
| Mar 31, 2023 | 3.28 Mn |
| Dec 31, 2022 | 3.12 Mn |
| Dec 31, 2022 | 3.12 Mn |
| Sep 30, 2022 | 3.20 Mn |
| Sep 30, 2022 | 3.20 Mn |
| Jun 30, 2022 | 2.97 Mn |
| Jun 30, 2022 | 2.97 Mn |
| Mar 31, 2022 | 2.46 Mn |
| Mar 31, 2022 | 2.46 Mn |
| Dec 31, 2021 | 2.45 Mn |
| Dec 31, 2021 | 2.45 Mn |
| Sep 30, 2021 | 2.29 Mn |
| Sep 30, 2021 | 2.29 Mn |
| Jun 30, 2021 | 1.91 Mn |
| Jun 30, 2021 | 1.91 Mn |
| Mar 31, 2021 | 1.32 Mn |
| Mar 31, 2021 | 1.32 Mn |
| Dec 31, 2020 | 767,200.00 |
| Dec 31, 2020 | 767,200.00 |
| Sep 30, 2020 | 598,000.00 |
| Sep 30, 2020 | 598,000.00 |
| Jun 30, 2020 | 559,000.00 |
| Jun 30, 2020 | 559,000.00 |